Top stories from TTO's May newsletter:
Five CU-Based Companies Receive State of Colorado Tech Commercialization Grants
New CU-Boulder Facility to Tackle Challenges Ranging from Cancer and Tissue Engineering to New Biofuels
A revolutionary research and teaching facility opening at the University of Colorado Boulder will facilitate work on a wide swath of pressing societal challenges ranging from biomedical issues like cancer, heart disease and tissue engineering to the development of new biofuels.
MiRagen Pockets $20M to Further miRNA-Based Drugs
CU licensee miRagen Therapeutics recently completed a $20M Series B financing. The company will use the money to advance development of its miRNA-based therapeutics pipeline.
Fast Company: How A Colorado Town's Med-Tech Startups Thrive On Shoestring Budgets, Stem Cells
In most cities, academic researchers have to drive across town, or even through other cities, to reach an industry incubator. In Aurora, they just walk across the street.
Read the full newsletter, or sign up to receive a monthly email update.
3 hours ago